186 related articles for article (PubMed ID: 16625857)
1. Pathophysiology of pituitary adenomas.
Donangelo I; Melmed S
J Endocrinol Invest; 2005; 28(11 Suppl International):100-5. PubMed ID: 16625857
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
3. Implication of pituitary tropic status on tumor development.
Donangelo I; Melmed S
Front Horm Res; 2006; 35():1-8. PubMed ID: 16809918
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms for pituitary tumorigenesis: the plastic pituitary.
Melmed S
J Clin Invest; 2003 Dec; 112(11):1603-18. PubMed ID: 14660734
[TBL] [Abstract][Full Text] [Related]
5. Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice.
El-Naggar SM; Malik MT; Martin A; Moore JP; Proctor M; Hamid T; Kakar SS
J Endocrinol; 2007 Jul; 194(1):179-91. PubMed ID: 17592032
[TBL] [Abstract][Full Text] [Related]
6. Transgenic and knockout mouse models clarify pituitary development, function and disease.
Asa SL
Brain Pathol; 2001 Jul; 11(3):371-84. PubMed ID: 11414478
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of "hyperplasia-adenoma sequence" in the pituitaries of transgenic mice expressing a human growth hormone-releasing factor gene.
Umemura S; Oda K; Utsunomiya H; Sanno N; Itoh J; Katakami H; Osamura RY
Tokai J Exp Clin Med; 1995 Jul; 20(2):71-9. PubMed ID: 8797263
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of pituitary tumors.
Yu R; Melmed S
Prog Brain Res; 2010; 182():207-27. PubMed ID: 20541667
[TBL] [Abstract][Full Text] [Related]
10. Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia type 1.
Weil RJ; Huang S; Pack S; Vortmeyer AO; Tsokos M; Lubensky IA; Oldfield EH; Zhuang Z
Cancer Res; 1998 Oct; 58(20):4715-20. PubMed ID: 9788627
[TBL] [Abstract][Full Text] [Related]
11. Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.
Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH
Endocrinology; 2003 Oct; 144(10):4626-36. PubMed ID: 12960102
[TBL] [Abstract][Full Text] [Related]
12. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
13. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias.
Sáez C; Japón MA; Ramos-Morales F; Romero F; Segura DI; Tortolero M; Pintor-Toro JA
Oncogene; 1999 Sep; 18(39):5473-6. PubMed ID: 10498901
[TBL] [Abstract][Full Text] [Related]
14. Transgenic models of pituitary diseases.
Stefaneanu L; Kovacs K
Microsc Res Tech; 1997 Oct; 39(2):194-204. PubMed ID: 9361270
[TBL] [Abstract][Full Text] [Related]
15. [Recent progress in experimental pituitary tumors in various animals].
Ishii J; Kawakami Y
Nihon Rinsho; 1993 Oct; 51(10):2580-4. PubMed ID: 8254925
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetic changes in hypophyseal adenomas].
Mennel HD
Strahlenther Onkol; 2001 Jul; 177(7):373-4. PubMed ID: 11505626
[No Abstract] [Full Text] [Related]
17. Mechanisms of disease: The pathogenesis of pituitary tumors.
Ezzat S; Asa SL
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):220-30. PubMed ID: 16932287
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of pituitary tumor transforming gene in tumorigenesis.
Tfelt-Hansen J; Kanuparthi D; Chattopadhyay N
Clin Med Res; 2006 Jun; 4(2):130-7. PubMed ID: 16809406
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumor transforming gene overexpression facilitates pituitary tumor development.
Donangelo I; Gutman S; Horvath E; Kovacs K; Wawrowsky K; Mount M; Melmed S
Endocrinology; 2006 Oct; 147(10):4781-91. PubMed ID: 16809444
[TBL] [Abstract][Full Text] [Related]
20. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
